As Vitality becomes the first UK insurance provider to offer discounted weight-loss jab treatment, Yahoo UK spoke to them to ...

Mounjaro and Ozempic have FDA approval for type 2 diabetes treatment, but not specifically for weight loss. So, chances are most commercial insurance plans won’t cover them for weight loss.

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, ...

Tirzepatide will be available at pharmacies in Ireland initially in doses of 2.5 mg and 5 mg, with availability of higher ...

This includes U.S. direct-to-consumer advertising on Zepbound and Mounjaro and U.S. launch activities for Kisunla and Ebglyss. We also increased our commercial investment outside the U.S. to ...

Employees are set to be able to get access to weight loss jabs through their workplace health, under a plan announced by ...

Wall Street is bullish on Viking, but the company still has a lot to prove. Viking has a number of different clinical studies ongoing with its lead GLP-1 candidate, VK2735, which ...

The View' host Whoopi Goldberg said an Instagram ad is using an AI version of her likeness to sell weight loss drugs without her consent.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.